Opportunities

Call for papers and Q&A: Pharmacoequity

This Collection invites research into pharmacoequity, including studies measuring equity and those testing methods to improve equity.

Collection Overview

Scientific Reports has launched a Guest-Edited Collection on Pharmacoequity.

Pharmacoequity is the goal for all individuals to be able to receive the optimal medication regimen. Achieving pharmacoequity requires filling multiple gaps in our biomedical system, from increasing medication coverage by insurers and improving medical and pharmacy care in rural and low-income areas to incentivizing production and storage capacity of drugs for rare diseases and understanding drug interactions and precision therapy. 

This will be a Collection of original research papers and will be open for submissions from all authors – on the condition that the manuscripts fall within the scope of the Collection and of Scientific Reports more generally. Narrative review articles are also welcomed to our sister journal, Scientific Reviews. We are welcoming submissions until 24th March 2027.

This Collection also amplifies and supports research related to SDG 3 - Good health and Wellbeing, SDG 5 - Gender equality, and SDG 10 - Reduced inequalities.

Q&A with Dr. Srinivas Goli (Guest Editor)

Why is this Collection important?

Pharmacoequity is central to health justice: access to safe, effective, and affordable medicines should depend on need, not income, gender, caste, ethnicity, or geography. 

Why are you excited about this Collection?

 My interest in health inequalities and healthcare financing makes this Collection particularly exciting, as it connects pharmaceutical innovation with equitable access and financial protection. I hope it will advance understanding of structural barriers, strengthen policy debates, and identify solutions for underserved populations. 

In your view, why should a researcher submit to this Collection?

Researchers should submit to this collection to contribute rigorous, interdisciplinary evidence that can inform fairer pharmaceutical policies, improve accountability, and help translate scientific progress into better health outcomes for all.

Why submit to a Collection? 

Collections like this one help promote high-quality science. They are led by Guest Editors, who are experts in their fields, and In-House Editors and are supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one-stop-shop on a cutting-edge topic of interest.

Who is involved? 

Guest Editors:

  • Srivnas Goli, International Institute for Population Sciences, India
  • Serena Jingchuan Guo, Purdue University, USA
  • Minghui Li, University of Tennessee Health Science Center, USA
  • Aditya Singh, Banaras Hindu University, India

Internal Team:

  • In-House Editor: Rachel Toth, Scientific Reports, USA
  • Commissioning Editor: Jenny Knowles, Fully OA Brands, Springer Nature, UK
  • Managing Editor: Aliya Anwar, Fully OA Brands, Springer Nature, UK

How can I submit my paper? 

Visit the Collection Page to find out more about this Collection and how to submit your article.